What an LPS antibody panel measures, and what it does not
These antibody levels can change with exposure, the immune response, the test method, and time. The panel reports how antibodies bind to LPS, not whether LPS moved through the gut wall. No proven clinical rule connects a high, low, or mixed result to a diagnosis or treatment.
Anti-LPS panel
It reports three antibody types
The laboratory checks how IgA, IgG, and IgM in the sample bind to LPS. Each result uses that laboratory's method and range.
Not direct LPS
It does not count endotoxin in blood
Direct LPS, LPS-binding protein, soluble CD14, and endotoxin-core antibodies are separate tests.
Does not measure gut permeability directly
Gut-barrier tests ask a different question
Tests that follow swallowed sugars ask whether small molecules cross the gut. This panel only measures antibody binding in blood.
Not a treatment target
Watch health, not only the antibody number
Judge care by symptoms, digestion, inflammation, thinking, nutrition, and the health condition being treated.
This panel can't confirm leaky gut, changed gut bacteria, food sensitivity, body-wide inflammation, depression, or the cause of brain fog.
Save this test
Save the test identity, not just the flag
My Fog keeps all three results with the laboratory method, preparation, symptoms, other tests, and next decision.
Repeat only when the same method can answer a clear question.
How age, sex, pregnancy, illness, and the immune system affect the result
There are no widely accepted anti-LPS ranges for age, sex, pregnancy, or menopause. Immune development, exposure, illness, medicines, and the test method can change antibody levels.
Babies and young children
An adult range doesn't apply to a baby. A 2018 study tested dried blood spots from 82 Peruvian infants aged 2 to 33 months. It studied sample handling for research, not a US anti-LPS panel or diagnosis in children.
Children and teenagers
A child needs usual medical testing for lasting diarrhea, blood in stool, weight loss, anemia, fever, celiac risk, or signs of inflammatory bowel disease. This panel should not delay care or lead to a severe diet during growth.
Adult women and men
There is no standard anti-LPS target for men or women. A study of gut sugar movement in 60 healthy adults aged 18 to 70 found no clear age or sex effect. That was not an antibody test.
Pregnancy and breastfeeding
There is no set range for pregnancy or breastfeeding. Ask whether the 12-hour fast is safe and whether to pause any medicine. This result is no reason for a strict diet or supplement plan.
Older adults and altered immune response
Age, liver disease, a weak immune system, immune treatment, serious illness, recent infection, and poor nutrition can change antibody production or LPS handling. Read the result with this health history.
How to prepare for an LPS antibody blood panel
Get the exact panel name and list of tests. Check whether it measures anti-LPS antibodies, endotoxin-core antibodies, direct LPS, LPS-binding protein (LBP), or another substance. One result can't replace another.
Ask what the result could change and which standard tests are already complete. Long-lasting diarrhea, bleeding, weight loss, anemia, fever, severe pain, or a family history of bowel disease needs a usual medical workup.
Follow the current collection sheet from your laboratory. Precision Point asks for a 12-hour fast and two EDTA tubes. The sample stays at 2 to 8 °C, must not freeze, and must arrive within six days. Other panels may differ.
That Precision Point panel also measures histamine and asks patients to stop antihistamines for five days. Never stop a prescription on your own. Ask the prescriber and laboratory whether a pause is safe or whether the test should wait.
Note recent infection, fever, diarrhea, vomiting, antibiotics, bowel preparation, surgery, a hospital stay, a disease flare, alcohol, a major food change, and immune-suppressing treatment. These events can change the result.
Save IgA, IgG, and IgM as three separate results. Keep each value, unit, range, laboratory, sample, date, fasting time, medicine plan, and the other panel tests.
Name the measurement
Record all three anti-LPS antibody types or the different endotoxin-related test actually ordered.
Keep the laboratory
Save the lab, method, specimen, units, interval, collection sheet, and FDA-clearance statement shown on the report.
Keep the clinical question
Record the symptom or disease question and the standard tests already done.
Read each antibody class
Keep IgA, IgG, and IgM separate. A high or low result cannot show where LPS exposure began or whether the gut barrier leaks.
Define the next decision
Ask whether the result changes a standard workup, supports a planned specialist review, or should not change care.
How to understand the three anti-LPS antibody results
Read each antibody against the range on that report. Then ask whether the test has a proven use for your health question. Keep the three results separate. Findings from a different endotoxin test don't apply.
Inside this laboratory's intervals
Each reported antibody class falls inside that laboratory's current interval
The values matched this laboratory's comparison group. If bowel symptoms continue, use the usual medical workup for those symptoms.
One or more antibody classes high
One or more anti-LPS antibody classes are above the printed interval
The test found more antibody binding than in this laboratory's comparison group. It cannot show how much LPS is in blood, where it came from, or which treatment to use.
One or more antibody classes low
One or more anti-LPS antibody classes are below the printed interval
A low value may reflect the test method, immune response, past exposure, treatment, or another factor. The flag alone gives no reason to try to stimulate the immune system.
Mixed or noncomparable panel
Mixed isotypes, changed laboratory or method, missing interval, or unclear specimen and preparation
Keep the three results separate. Check the exact panel, method, sample, preparation, and ranges. Repeat only when it could answer a clear health question.
Neither high nor low proves that endotoxin crossed from the gut
Exposure and the immune response both affect antibody levels. Studies of different markers have found changes in both directions.
See research details
The notes explain the current commercial test, its ranges and preparation, related research markers, and what the studies can support.
Use only the interval printed with the actual result. Keep the report version and method, and do not convert a CLIA laboratory's interval into proof of clinical validity for a leaky-gut diagnosis.
Before interpreting a paper or report, match the analyte, antibody class, antigen, specimen, method, unit, and population. Findings from a different endotoxin test don't apply here.
This cross-sectional association does not validate a diagnostic cutoff, prove food sensitivity, identify the source of LPS exposure, or show that treating the antibody number improves symptoms.
Use symptoms and standard disease pathways first. A specialty antibody result shouldn't replace celiac testing, inflammatory markers, stool testing, endoscopy, imaging, or another check you need.
These studies support ongoing research in defined disease groups. They do not validate commercial three-isotype intervals for general fatigue, brain fog, or digestive symptoms.
An anti-LPS result can't diagnose depression, explain cognitive symptoms, or choose a gut treatment. Mood, sleep, medicines, anemia, thyroid, infection, and other plausible causes still need their own assessment.
Do not interpret high as confirmed translocation or low as immune failure. Keep the antibody class and exact study population attached to every claim.
What you can do while the result is being reviewed
An LPS antibody number isn't something to treat with food, supplements, a cleanse, or antimicrobials. Start with your symptoms and any condition that has been diagnosed.
Write the problem before changing food
For one to two weeks, record how often you pass stool and what it looks like. Add pain, bloating, vomiting, fever, blood, weight change, meals, alcohol, medicines, sleep, and activities you could not do. This can help choose the next test.
Keep ordinary food broad when it is safe
Eat regular foods you tolerate and drink enough. Include different fiber foods when they are safe for you. Record a food that causes the same clear problem each time, then discuss a short, planned check. This panel isn't a reason to remove many foods.
Treat the named condition, not a permeability label
Celiac disease, inflammatory bowel disease, infection, medicine injury, diabetes, liver disease, and severe poor nutrition each need their own tests and care. Treat the condition that's found.
Ask whether a repeat would change care
Before paying again, ask what change would matter and whether the same method will be used. Judge progress by symptoms, weight, bleeding, inflammation, nutrition, and daily function instead of an unproven target.
One report doesn't justify starting antibiotics, antimicrobial herbs, binders, detox products, probiotics, glutamine, high-dose zinc, fasting, or a severe diet. Get prompt care for black or bloody stool, severe pain in one area of the belly, lasting vomiting, dehydration, high fever, fainting, confusion, or fast worsening.
What to save with an LPS antibody result
Keep these together
- Laboratory, panel name and version, order code, sample, method, draw date, and report date
- IgA, IgG, and IgM as separate values, with each unit, range, flag, and any combined score
- Fasting time, collection and shipping guide, medicine plan, antihistamines, antibiotics, immune treatment, and supplements
- Recent infection, gut symptoms, stool changes, fever, bleeding, weight change, surgery, bowel preparation, alcohol, food changes, and diagnosed conditions
- Other panel tests, usual symptom-based tests, the clinician's reading, what remains unclear, repeat conditions, and next decision
Question for the visit
“Does this anti-LPS result have a proven use for our question? What usual test or clear decision should come before another panel or treatment?”
Sources for LPS Antibody Blood Test (IgA, IgG, and IgM)
Current LPS IgA, IgG, and IgM intervals, units, specimen, and FDA-clearance statement.
Fasting, medicine warning, EDTA collection, refrigeration, shipping, and stability instructions.
A second commercial three-isotype panel showing that products and methods differ.
Current clinical review stating that general leaky gut syndrome lacks a validated blood or stool diagnostic test.
Barrier-measurement distinctions and the limit of symptom claims from restoring permeability.
Comparison of proposed surrogate markers with oral-probe permeability testing in two small adult cohorts.
Validated sugar-probe research in 60 healthy adults and 18 people with IBS-D, not an antibody panel.
Cross-sectional anti-LPS isotype ELISA study in 111 adults, including its symptom and direction limits.
Selected cirrhosis-cohort research using EndoCAb, LPS-binding protein, and other proposed markers.
Small type 1 diabetes study using EndoCAb, direct LPS, LPS-binding protein, biopsies, and symptoms.
Depression meta-analysis of several permeability and endotoxin-response biomarkers, with no personal cutoff or treatment pathway.
Technical EndoCAb dried-blood-spot validation in 82 Peruvian infants, not pediatric clinical validation of anti-LPS panels.
Repeated direct LPS and anti-LPS isotype findings in 23 adults with short bowel syndrome.
US patient guidance on IgA, IgG, IgM, and reasons antibody production can differ.
See each claim's sources
procedure
One current US plasma panel lists LPS IgA 0.83 to 4.47, IgG 9.09 to 31.5, and IgM 2.5 to 9.4 µg/mL and states that the laboratory-developed test is not FDA cleared.limitation
Older and current sample reports from the same laboratory publish substantially different LPS antibody intervals, so the report version and method must remain attached.procedure
The current panel collection sheet calls for a 12-hour fast, EDTA collection, refrigerated handling, no freezing, and arrival within six days.limitation
Anti-LPS isotype ELISA measures antibody binding to LPS and is distinct from direct LPS, LPS-binding protein, soluble CD14, EndoCAb, and oral-probe permeability tests.limitation
No validated blood or stool test currently diagnoses a general leaky gut syndrome.limitation
A 111-adult cross-sectional study found selected anti-LPS associations but no difference in permeability biomarkers between symptomatic and asymptomatic participants and could not establish direction or diagnostic validity.limitation
Recent cirrhosis and type 1 diabetes studies use EndoCAb and other surrogate markers in selected cohorts and do not validate general commercial anti-LPS isotype cutoffs.limitation
A 2025 meta-analysis found group associations for several gut-barrier biomarkers but did not establish an anti-LPS diagnostic cutoff or treatment pathway for depression or cognitive symptoms.limitation
High and low endotoxin-related antibody values are not simple opposites because exposure, immune response, clearance, disease stage, and assay affect direction.limitation
EndoCAb dried-blood-spot validation in 82 Peruvian infants does not validate adult commercial anti-LPS panel intervals for children.